Fagron Compounding Services Vancomycin HCL, 1 gram added to 250 mL recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
The hazard: Sterility or particulate concern
Particulate matter or a sterility failure prompted this notice, the most common reason injectable and ophthalmic products are withdrawn.
What the notice says: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Why it matters: The product was made or packaged in conditions that cannot assure sterility, or visible particles were found in it. For anything injected, infused or used in the eye, that is a direct route for contamination into the body.
Symptoms and when to call a doctor
Watch for fever, chills, pain, redness, swelling or discharge at an injection site, and for a red, painful or suddenly blurred eye after using an eye product. Any of these needs same-day medical attention. Do not wait to see whether it settles, and tell the clinician which product and lot you used so it can be reported against the recall.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0442-2026
- Published
- April 15, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Fagron Compounding Services
- Product type
- Prescription & OTC drugs
- Units affected
- 11,680 bags
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot: C274-000050987, Exp.:7/12/2026; C274-000049425, Exp.: 5/2/2026; C274-000050069, Exp.: 5/30/2026; C274-000050346, Exp.: 6/10/2026; C274-000050698, Exp.: 6/27/2026; C274-000050699, Exp.:6/27/2026; C274-000050775, Exp.:7/4/2026.
Products covered by this recall
Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01
Check your product
The notice names 4 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- C274-000050987
NDC number
On the carton and again on the bottle or blister label.
- 71266-5082-01
Package size
Match the net weight or the piece count on the front of the pack.
- 1 gram
- 250 mL
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Sterility
Fagron Compounding Services — Particulate matter or a sterility failure prompted this notice, the most common reason injectable and ophthalmic products are withdrawn.
- Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
- If you are a clinic or pharmacy, quarantine the stock and work it through your usual recall log.
- Report any infection or reaction you think the product caused to FDA MedWatch.
- Do not use a vial or syringe with visible particles, cloudiness or discolouration, whether or not it is on the recall list.
What the company owes you
A recalled medicine is the manufacturer’s cost to carry, not yours or your pharmacist’s.
- The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
- Ask the pharmacy to handle the claim where they can — they process recall returns in bulk and it saves you the correspondence.
- Keep the carton, the leaflet and the pharmacy label together until the claim is closed.
- Costs beyond the price of the medicine need to go to the company directly, in writing, with the recall number quoted.
Company contact: Fagron Compounding Services — 8710 E 34th St N, Wichita, KS, 67226-2636
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Fagron Compounding Services prescription & otc drugs recalled?
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code C274-000050987. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
Can I get my money back?
The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 6 months ago
Fagron Compounding Services Vancomycin HCI, 1.5 grams added to 250 mL recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 6 months ago
Fagron Compounding Services Vancomycin HCI, 1.25 grams added to 250 mL recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 6 months ago
Fagron Compounding Services norepinephrine Bitartrate recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 6 months ago
Fagron Compounding Services norepinephrine Bitartrate recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 10 months ago
Fagron Compounding Services Tropicamide 1%/Cyclopentolate 1%/Phenylephrine recall: Incorrect Product Formulation
Incorrect Product Formulation
-
Class II · 1+ years ago
Fagron Compounding Services bevacizumab Injection, 1.25mg/0.05mL recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility